Literature DB >> 1688565

Stimulation of CD5 enhances signal transduction by the T cell antigen receptor.

J B Imboden1, C H June, M A McCutcheon, J A Ledbetter.   

Abstract

After the addition of a CD3 monoclonal antibody to peripheral T cells that have been previously stimulated with phytohemagglutinin, inositol phosphates are produced at a rapid rate for 2 min and at a much slower rate thereafter. Stimulation of CD5 allows CD3-mediated production of inositol phosphates to be sustained at a brisk rate for greater than 20 min and augments the initial CD3-mediated increase in inositol trisphosphate and release of intracellular Ca2+. Thus, perturbation of CD5 by monoclonal antibody enhances the ability of the CD3-antigen receptor complex to couple to the inositol phospholipid pathway. This effect of CD5 is independent of any direct effect of the CD5 monoclonal antibody on the levels of inositol phosphates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688565      PMCID: PMC296396          DOI: 10.1172/JCI114402

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1.

Authors:  N H Jones; M L Clabby; D P Dialynas; H J Huang; L A Herzenberg; J L Strominger
Journal:  Nature       Date:  1986 Sep 25-Oct 1       Impact factor: 49.962

2.  Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.

Authors:  J L Ceuppens; M L Baroja
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

3.  Signal transduction through CD4 receptors: stimulatory vs. inhibitory activity is regulated by CD4 proximity to the CD3/T cell receptor.

Authors:  J A Ledbetter; C H June; P S Rabinovitch; A Grossmann; T T Tsu; J B Imboden
Journal:  Eur J Immunol       Date:  1988-04       Impact factor: 5.532

4.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.

Authors:  J E Sims; C J March; D Cosman; M B Widmer; H R MacDonald; C J McMahan; C E Grubin; J M Wignall; J L Jackson; S M Call
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

Review 5.  Cell surface molecules and early events involved in human T lymphocyte activation.

Authors:  A Weiss; J B Imboden
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

6.  Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: molecular homology to its human counterpart Leu-1/T1 (CD5).

Authors:  H J Huang; N H Jones; J L Strominger; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 7.  Studies and perspectives of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

8.  Tyrosine kinase-activating growth factors potentiate thrombin- and AIF4- -induced phosphoinositide breakdown in hamster fibroblasts. Evidence for positive cross-talk between the two mitogenic signaling pathways.

Authors:  S Paris; J C Chambard; J Pouysségur
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

9.  CD5 antibodies increase intracellular ionized calcium concentration in T cells.

Authors:  C H June; P S Rabinovitch; J A Ledbetter
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

10.  Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen).

Authors:  T Hara; S M Fu; J A Hansen
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more
  6 in total

1.  CD5 is dissociated from the B-cell receptor in B cells from bovine leukemia virus-infected, persistently lymphocytotic cattle: consequences to B-cell receptor-mediated apoptosis.

Authors:  G H Cantor; S M Pritchard; F Dequiedt; L Willems; R Kettmann; W C Davis
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Characterization of porcine CD5 and CD5+ B cells.

Authors:  G D Appleyard; B N Wilkie
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

3.  CD5 (OKT1) augments CD3-mediated intracellular signaling events in human T lymphocytes.

Authors:  S M Berney; T Schaan; R E Wolf; D L Kimpel; H van der Heyde; T P Atkinson
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

4.  CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex.

Authors:  A A Davies; S C Ley; M J Crumpton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

5.  CD6 attenuates early and late signaling events, setting thresholds for T-cell activation.

Authors:  Marta I Oliveira; Carine M Gonçalves; Mafalda Pinto; Stéphanie Fabre; Ana Mafalda Santos; Simon F Lee; Mónica A A Castro; Raquel J Nunes; Rita R Barbosa; Jane R Parnes; Chao Yu; Simon J Davis; Alexandra Moreira; Georges Bismuth; Alexandre M Carmo
Journal:  Eur J Immunol       Date:  2011-11-28       Impact factor: 5.532

6.  T-cell modulatory properties of CD5 and its role in antitumor immune responses.

Authors:  Mouna Tabbekh; M'barka Mokrani-Hammani; Georges Bismuth; Fathia Mami-Chouaib
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.